FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
PO:14:195 | Real-world effectiveness of anifrolumab in achieving treatment targets and reducing systemic lupus erythematosus disease burden: 6-month interim analysis of the REVEAL study Chiara Cardelli1|2, Chiara Tani1, Luca Moroni3, Filippo Vesentini4, Francesca Bottazzi5, Micaela Fredi6, Ettore Silvagni7, Matteo Piga8, Flavia Riccio9, Fulvia Ceccarelli10, Ginevra De Marchi11, Edoardo Biancalana12, Gianluca Moroncini13, Rita Mulè14, Mariele Gatto15, Laura Coladonato16, Paola Conigliaro17, Maria Gerosa18, Andrea Picchianti Diamanti19, Benedetta Bianchi20, Federica Maiolini20, Michela Gasparotto20, Serena Guiducci20, Maria Ilenia De Andres20, Alberto Lo Gullo20, Silvia Noviello20, On Behalf Of The Reveal Investigators20, Marta Mosca1. | 1Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa; 2Department of Medical Biotechnologies, University of Siena, Siena; 3Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano; 4Rheumatology Unit, Department of Medicine, University of Padua, Padova; 5Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 6Rheumatology and Clinical Immunology, Department of Clinical and Experimental Sciences, University of Brescia, Brescia; 7Section of Rheumatology, Department of Medical Sciences, University of Ferrara; AOU Sant'Anna, Ferrara; 8Rheumatology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari; 9Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli; 10Rheumatology Unit, Dept. of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Roma; 11Division of Rheumatology, Department of Medicine, Azienda Sanitaria Universitaria del Friuli Centrale, Udine; 12Internal Interdisciplinary Medicine Unit, Department of Experimental and Clinical Medicine, University of Florence, Firenze; 13Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona; 14Azienda Ospedaliero-Universitaria di Bologna, Internal Medicine and Rheumatology, IRCCS S. Orsola Malpighi, Bologna; 15Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin; AO Mauriziano, Torino; 16Rheumatology Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari, Bari; 17Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, Tor Vergata University of Rome, Roma; 18Clinical Rheumatology, ASST Gaetano Pini CTO; Department of Clinical Sciences and Community Health, University of Milano, Milano; 19Department of Clinical and Molecular Medicine, Sapienza University of Rome; AOU Sant'Andrea, Roma, Italy; 20Italian REVEAL Study Group Italy, Italy
173 -
PO:19:279 | Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry Jessica Sbalchiero1, Antonio Vitale1, Valeria Caggiano1, Abdurrahman Tufan2, Ezgi Batu3, Gaafar Ragab4, Seza Ozen3, Jurgen Sota1, Carla Gaggiano1, Ali Sahin5, Petros Sfikakis6, Francesca Li Gobbi7, Giacomo Emmi8, Jose Rodriguez9, Piero Ruscitti10, Paolo Sfriso11, Ewa Szewczyk12, Giuseppe Lopalco13, Alberto Balistreri14, Claudia Fabiani15, Bruno Frediani1, Luca Cantarini1 | 1Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy; 2Department of Internal Medicine, Division of Rheumatology, Gazi University Hospital Ankara, Turkey; 3Division of Pediatric Rheumatology, Department of Pediatrics, Hacettepe University School of Medicine Ankara, Turkey; 4Internal Medicine Department, Rheumatology and Clinical Immunology Unit, Faculty of Medicine, Cairo University Giza, Egypt; 5Division of Rheumatology, Department of Internal Medicine, Sivas Cumhuriyet University Medical Faculty Sivas, Turkey; 6Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens Athens, Greece; 7Rheumatology Unit, Hospital S. Giovanni di Dio, Azienda USL-Toscana Centro Florence, Italy; 8Clinical Medicine and Rheumatology Unit, Cattinara University Hospital Trieste, Italy; 9Department of Autoimmune Diseases, Institut Investigacions Biomediques August Pi I Sunyer, University of Barcelona Barcelona Spain; 10Rheumatology Unit, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy; 11Rheumatology Unit, Department of Medicine, University of Padua Padua, Italy; 127Department of Internal Medicine, Pneumonology, Allergology, Clinical Immunology and Rare Diseases, Military Institute o Warsaw, Poland; 13Department of Precision and Regenerative Medicine and Ionian Area DiMePRe-J Policlinic Hospital, University of Bari Bari, Italy; 14Bioengineering and Biomedical Data Science Lab, Department of Medical Biotechnologies, University of Siena Siena, Italy; 15Ophthalmology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena Siena, Italy
40 -
PO:06:086 | Updated Systematic Literature Review and meta-analysis to Inform the Italian Society of Rheumatology Recommendations on the Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease Angelo Fassio1, Marco Sebastiani9|10, Francesco Pollastri1, Chiara Crotti4, Nicola Ughi5, Enrico De Lorenzis6, Silvia Mancuso7, Massimo Radin8, Francesca Cozzini9, Greta Carrara11, Gianpiero Landolfi11, Roberto Rozza11, Andreina Manfredi2|3 | 1Rheumatology Unit, University of Verona, Verona, Italy; 2University of Modena and Reggio Emilia, Reggio Emilia, Italy; 3Rheumatology Unit, AUSL-IRCCS, Reggio Emilia, Italy; 4Bone Disease Unit, Department of Rheumatology and Medical Science, ASST-G.Pini-CTO, Milan, Italy; 5Division of Rheumatology, Multispecialist Medical Department, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; 6Department of Aging Diseases, Orthopedic and Rheumatology, Rheumatology Division, P. Gemelli, Roma, Italy; 7Rheumatology Unit, Department of Clinical, Internal, Anaesthesiologic and Cardiovascular, Sciences, Sapienza, Roma, Italy; 8CMID, San Giovanni Bosco Hub Hospital ASL Città di Torino and Department of Clinical and Biological Sciences, Turin, Italy; 9Department of Medicine and Surgery, University of Parma, Parma, Italy; 10Rheumatology Unit, AUSL Piacenza, Piacenza, Italy; 11Unità Epidemiologica, SIR, Società Italiana di Reumatologia, Milano, Italy
23 -
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies
2210PDF: 431SUPPLEMENTARY MATERIAL: 344 -
PO:33:200 | Analysis of risk factors associated with vertebral fractures in systemic sclerosis: evidence from the "Sclero-RER" study group Alessandra Bezzi1, Federica Lumetti2, Martina Orlandi3, Fabio Mascella1, Maria Cristina Focherini1, Eugenio Arrigoni4, Elena Bravi4, Andrea Lo Monaco5, Amelia Spinella3, Ottavio Secchi3, Gianluigi Bajocchi6, Francesco Girelli7, Francesco Ursini8, Pierluigi Cataleta9, Massimo Reta10, Alarico Ariani11|12, Dilia Giuggioli3 | 1Internal Medicine and Rheumatology Unit, AUSL Romagna, Rimini 2AUSL of Modena and Rheumatology Unit, University Hospital Policlinico of Modena; 3Rheumatology Unit, University of Modena and Reggio Emilia; 4Rheumatology Unit, Guglielmo da Saliceto Hospital, Piacenza; 5Rheumatology, department of medical sciences, University of Ferrara; 6Rheumatology Unit, IRCCS Arcispedale Santa Maria Nuova Reggio Emilia; 7Rheumatology Unit, G.B. Morgagni - L. Pierantoni Hospital, Forlì; 8Rizzoli Orthopedic Institute, Rheumatology Unit, Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum Bologna; 9Hospital Santa Maria delle Croci, Rheumatology Unit, Department of Internal medicine, AUSL-Romagna Ravenna; 10Rheumatology Unit, AUSL of Bologna, Sant'Orsola Polyclinic Hospital, AOU IRCCS of Bologna; 11Internal Medicine and Rheumatology Unit, University Hospital of Parma; 12AUSL Bologna and University of Bologna, IRCCS Policlinico Sant'Orsola, Bologna, Italy
138 -
CO:01:4 | Identify predictors of relapse in idiopathic inflammatory myopathies: insights from an international cohort Cristina Bochicchio1|2, Maria Rosa Pellico1|2, Claudia Iannone1|2, Lekshmi Minikumari Rahulan3, Marco Fornaro4, Ilaria Cavazzana5, Edoardo Conticini6, Musataka Musataka7, Akira Yoshida7, Silvia Cavalli1|2, Silvia Grazzini6, Giulio Fraticelli8, Alessia Gatti5, Giulio Lopinto4, Paolo Semeraro5, Veronica Batani8, Thomas Patric Sheeran9, Florenzo Iannone4, Giacomo De Luca8, Roberto Caporali1|2, Latika Gupta9|10|11, Nicoletta Del Papa2. | 1Department of Clinical Sciences and Community Health, University of Milano; 2Department of Rheumatology and Medical Sciences, ASST Gaetano Pini-CTO Institute, Milano, Italy; 3Rheumatology "Sanjay Gandhi" Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India; 4Unit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica, University of Bari; 5Rheumatology and Clinical Immunology Unit, ASST Spedali Civili di Brescia; 6Rheumatology Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Italy; 7Department of Allergy and Rheumatology Nippon Medical School Graduate School of Medicine, Tokyo, Japan; 8Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; 9Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK; 10Francis Crick Institute, London, UK; 11School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham, UK
201
